Transcat, Inc. (NASDAQ:TRNS) Receives $127.25 Average Target Price from Analysts

Transcat, Inc. (NASDAQ:TRNS) has received a consensus recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $130.25.

Several analysts have recently weighed in on the stock. Oppenheimer restated an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. HC Wainwright restated a “buy” rating and set a $156.00 price objective on shares of Transcat in a research report on Tuesday, October 29th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. Craig Hallum lifted their target price on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a report on Thursday. Finally, Northland Securities cut their target price on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th.

Transcat Stock Down 1.9 %

Shares of Transcat stock opened at $109.12 on Monday. Transcat has a 52-week low of $94.29 and a 52-week high of $147.12. The company has a 50 day moving average of $111.36 and a 200 day moving average of $119.31. The company has a market capitalization of $1.00 billion, a P/E ratio of 55.11 and a beta of 0.70.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). The company had revenue of $67.83 million for the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.41 EPS. As a group, research analysts anticipate that Transcat will post 1.76 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Transcat

Institutional investors have recently modified their holdings of the business. DekaBank Deutsche Girozentrale acquired a new position in Transcat in the 2nd quarter valued at $40,000. nVerses Capital LLC acquired a new position in Transcat in the 3rd quarter valued at $60,000. First Horizon Advisors Inc. increased its stake in Transcat by 26.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock valued at $72,000 after buying an additional 125 shares during the period. Fifth Third Bancorp increased its stake in Transcat by 95.8% in the 2nd quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company’s stock valued at $79,000 after buying an additional 321 shares during the period. Finally, Quest Partners LLC acquired a new position in Transcat in the 2nd quarter valued at $109,000. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.